Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PPP | Ann: 2016 Annual Report | 29/09/16 | 0 | 625 | |||
|
|||||||
PPP | Ann: Directors Contract | 29/09/16 | 0 | 650 | |||
|
|||||||
PPP | Ann: Letter to shareholders on the NZX | 15/09/16 | 0 | 633 | |||
|
|||||||
PPP | Ann: Memo - Pan Pacific Petroleum (“PPP”) – Delisting | 12/09/16 | 0 | 729 | |||
|
|||||||
PPP | Ann: PPP advises of Delisting from the NZX | 08/09/16 | 0 | 619 | |||
|
|||||||
PPP | Ann: 2016 Corporate Governance Statement and Appendix 4G | 30/08/16 | 0 | 651 | |||
|
|||||||
PPP | Ann: 2016 Appendix 4E and Annual Financial Report | 30/08/16 | 0 | 613 | |||
|
|||||||
PPP | Ann: June 2016 Quarterly Report | 28/07/16 | 0 | 710 | |||
|
See All Discussions